A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE2
To investigate the safety and tolerability of repeated subcutaneous (s.c.) ...
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
PHASE1
The clinical study consists of three parts:
* Part 1 with healthy voluntee...
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
PHASE2
This is a Phase II, randomized, double-blind, placebo-controlled multicente...
Status
Terminated
Location
Fachklinik Bad Bentheim, Department of Dermatology